These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 6517765)
21. Antibodies to outer membrane proteins of Vibrio cholerae induce protection by inhibition of intestinal colonization of vibrios. Sengupta DK; Sengupta TK; Ghose AC FEMS Microbiol Immunol; 1992 Jul; 4(5):261-6. PubMed ID: 1515155 [TBL] [Abstract][Full Text] [Related]
22. Antigens involved in resistance to mucosal association by Vibrio cholerae. Narendranathan R; Lutze LH; Jackson GD; Cooper GN J Med Microbiol; 1988 Feb; 25(2):129-38. PubMed ID: 3339633 [TBL] [Abstract][Full Text] [Related]
23. Local immune response in mice to Vibrio cholerae. Bloom LD; Rowley D Aust J Exp Biol Med Sci; 1979 Jun; 57(3):313-23. PubMed ID: 394733 [TBL] [Abstract][Full Text] [Related]
24. Antibacterial immunity to Vibrio cholerae in rats. Cooper GN; Narendranathan R J Med Microbiol; 1986 Sep; 22(2):133-41. PubMed ID: 3746875 [TBL] [Abstract][Full Text] [Related]
25. Cell-bound haemagglutinin (CHA) of V. cholerae 01 as protective antigen. Chaicumpa W; Boonthum A; Kalumbaheti T; Tapchaisri P Southeast Asian J Trop Med Public Health; 1984 Sep; 15(3):407-13. PubMed ID: 6523176 [TBL] [Abstract][Full Text] [Related]
26. Human immune response to the 18-kDa outer-membrane antigen of Vibrio cholerae. Sciortino CV J Med Microbiol; 1993 Aug; 39(2):135-40. PubMed ID: 8345508 [TBL] [Abstract][Full Text] [Related]
27. Biliary immune response to orally presented food antigen, ovomucoid, and its potentiation by cholera toxin B subunit. Sugita-Konishi Y; Kumagai S Scand J Immunol; 1992 May; 35(5):597-602. PubMed ID: 1579860 [TBL] [Abstract][Full Text] [Related]
28. Immune responses of rats to live Vibrio cholerae: antibodies in serum and intestinal secretions. Cooper GN; Jackson GD Parasite Immunol; 1981; 3(1):57-68. PubMed ID: 7220079 [TBL] [Abstract][Full Text] [Related]
29. Immunological properties of complex conjugates based on Vibrio cholerae O1 Ogawa lipopolysaccharide antigen. Paulovicová E; Machová E; Hostacká A; Bystrický S Clin Exp Immunol; 2006 Jun; 144(3):521-7. PubMed ID: 16734622 [TBL] [Abstract][Full Text] [Related]
30. Murine immune responses to Salmonella lipopolysaccharide: oral administration of whole bacteria to C3H/HeJ mice induces secondary anti-LPS responses, especially of the IgA isotype. Jirillo E; Kiyono H; Michalek SM; McGhee JR J Immunol; 1984 Apr; 132(4):1702-11. PubMed ID: 6366051 [TBL] [Abstract][Full Text] [Related]
31. Isolation and biological properties of three classes of rabbit antibody to Vibrio cholerae. Steele EJ; Chaicumpa W; Rowley D J Infect Dis; 1974 Aug; 130(2):93-103. PubMed ID: 4842331 [No Abstract] [Full Text] [Related]
32. Plant-based production of two chimeric monoclonal IgG antibodies directed against immunodominant epitopes of Vibrio cholerae lipopolysaccharide. Levinson KJ; Giffen SR; Pauly MH; Kim DH; Bohorov O; Bohorova N; Whaley KJ; Zeitlin L; Mantis NJ J Immunol Methods; 2015 Jul; 422():111-7. PubMed ID: 25865265 [TBL] [Abstract][Full Text] [Related]
33. Immune responses in chickens against Salmonella typhimurium monitored with egg antibodies. Schiemann DA; Montgomery AL Vet Microbiol; 1991 May; 27(3-4):295-308. PubMed ID: 1882506 [TBL] [Abstract][Full Text] [Related]
34. Immunological memory after immunization with oral cholera B subunit--whole-cell vaccine in Swedish volunteers. Jertborn M; Svennerholm AM; Holmgren J Vaccine; 1994 Sep; 12(12):1078-82. PubMed ID: 7998416 [TBL] [Abstract][Full Text] [Related]
35. Vibriocidal antibody and antibodies to Vibrio cholerae lipopolysaccharide, cell-bound haemagglutinin and toxin in Thai population. Chongsa-nguan M; Chaicumpa W; Kalambaheti T; Soejoedi H; Luxananil P; Swasdikosa S; Thanasiri P; Mayurasakorn S Southeast Asian J Trop Med Public Health; 1986 Dec; 17(4):558-66. PubMed ID: 3576285 [TBL] [Abstract][Full Text] [Related]
36. The localization of the antibody response in milk or bile depends on the nature of the antigen. Dahlgren UI; Ahlstedt S; Hanson LA J Immunol; 1987 Mar; 138(5):1397-402. PubMed ID: 2879867 [TBL] [Abstract][Full Text] [Related]
37. Assessment of antibody responses and protective immunity in cholera vaccinated subjects. Chaicumpa W; Pacharaprakiti C; Plueksawan W; Atthasishtha N Southeast Asian J Trop Med Public Health; 1980 Mar; 11(1):58-66. PubMed ID: 7403955 [TBL] [Abstract][Full Text] [Related]
38. Immunogenicity and protective role of three formulations of oral cholera vaccine. Kalambaheti T; Chaisri U; Srimanote P; Pongponratn E; Chaicumpa W Vaccine; 1998; 16(2-3):201-7. PubMed ID: 9607031 [TBL] [Abstract][Full Text] [Related]
39. Mucosal immunity. Hanson LA; Ahlstedt S; Andersson B; Carlsson B; Cole MF; Cruz JR; Dahlgren U; Ericsson TH; Jalil F; Khan SR; Mellander L; Schneerson R; Edén CS; Söderström T; Wadsworth C Ann N Y Acad Sci; 1983 Jun; 409():1-21. PubMed ID: 6191608 [TBL] [Abstract][Full Text] [Related]
40. Prophylactic significance of the nonlipopolysaccharide antigens of Vibrio cholerae. Attridge SR; Rowley D J Infect Dis; 1983 Nov; 148(5):931-9. PubMed ID: 6195273 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]